Send to

Choose Destination
Haematologica. 2018 Nov;103(11):1756-1757. doi: 10.3324/haematol.2018.201897.

To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia.

Author information

Vaccine and Infectious Diseases and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA.
Department of Medicine, University of Washington, Seattle, WA.
Department of Oncology Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center